Maria Marples

Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial

Beatrice Seddon, Sandra J. Strauss, Jeremy Whelan et al. · The Lancet Oncology · 2017 · 527 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Use of CA-125 to Define Progression of Ovarian Cancer in Patients With Persistently Elevated Levels

Gordon Rustin, Maria Marples, Ann E. Nelstrop et al. · Journal of Clinical Oncology · 2001 · 203 citations

Medicine, Gynecology, Oncology +17

Adjuvant bevacizumab in patients with melanoma at high risk of recurrence (AVAST-M): preplanned interim results from a multicentre, open-label, randomised controlled phase 3 study

Pippa Corrie, Andrea Marshall, Janet Dunn et al. · The Lancet Oncology · 2014 · 109 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial

Pippa Corrie, Pippa Corrie, Andrea Marshall et al. · Annals of Oncology · 2018 · 67 citations · Full text

Medicine, Clinical Sciences, Oncology +15

Patterns of Expression of DNA Repair Genes and Relapse From Melanoma

Rosalyn Jewell, Caroline Conway, Angana Mitra et al. · Clinical Cancer Research · 2010 · 61 citations · Full text

Life Sciences, Cancer Biology, Dna Repair +16